Thank you, Mr. Chair.
Thank you, Minister, for being with us, and thank you to this incredible panel of department officials as well. This is certainly a critical discussion for Canadians.
I'll just pick up on the last piece, on the question around diversion. I know it's an important topic that we'd like to address. I think nobody would be surprised to know that of course diversion is illegal. It's an issue that applies to all prescription drugs in Canada.
We have many doctors around the table, and I'm sure they make tough clinical decisions in their practices in balancing the benefits and risks of intervention. Can you talk about mitigation measures put in place to diminish the risk of diversion?